ORKA Oruka Therapeutics, Inc.

USD 25.65 -0.45 ( -1.72)%
Icon

Oruka Therapeutics, Inc. (ORKA) Stock Analysis and Price Targets

COMMON STOCK | Others | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 25.65

-0.45 (-1.72)%

USD 0.89B

0.26M

USD 42.50(+65.69%)

N/A

Icon

ORKA

Oruka Therapeutics, Inc. (USD)
COMMON STOCK | NSD
USD 25.65
-0.45 ( -1.72)%
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.89B

N/A

USD 25.65

Oruka Therapeutics, Inc. (ORKA) Stock Forecast

Show ratings and price targets of :
USD 42.50
(+65.69%)

Based on the Oruka Therapeutics, Inc. stock forecast from 4 analysts, the average analyst target price for Oruka Therapeutics, Inc. is USD 42.50 over the next 12 months. Oruka Therapeutics, Inc.’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Oruka Therapeutics, Inc. is Very Bullish, which is based on 1 positive signals and 0 negative signals. At the last closing, Oruka Therapeutics, Inc.’s stock price was USD 25.65. Oruka Therapeutics, Inc.’s stock price has changed by -7.20% over the past week, -1.50% over the past month and 0% over the last year.

No recent analyst target price found for Oruka Therapeutics, Inc.
No recent average analyst rating found for Oruka Therapeutics, Inc.

Company Overview Oruka Therapeutics, Inc.

Oruka Therapeutics, Inc. operates as a biotechnology company. The Company develops novel biologics designed for the treatment of chronic skin diseases, including plaque psoriasis and other inflammatory diseases. Oruka Therapeutics serves patients in the United States.

N/A

N/A

N/A

N/A

USD

USA

Adjusted Closing Price for Oruka Therapeutics, Inc. (ORKA)

Loading...

Unadjusted Closing Price for Oruka Therapeutics, Inc. (ORKA)

Loading...

Share Trading Volume for Oruka Therapeutics, Inc. Shares

Loading...

Compare Performance of Oruka Therapeutics, Inc. Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ORKA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Oruka Therapeutics, Inc. (Sector: Others )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
QQQM
Invesco NASDAQ 100 ETF -0.30 (-0.14%) USD34.39B N/A N/A

Frequently Asked Questions About Oruka Therapeutics, Inc. (ORKA) Stock

Based on ratings from 4 analysts Oruka Therapeutics, Inc.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bullish. The stock has 4 buy, sell and hold ratings.

ORKA stock's dividend yield is 77.77%. Our analysis grades ORKA stock's dividend yield at A+. This means that ORKA stock's dividend yield is above 97% of the stocks in the Others sector in the NSD exchange. Based on this ORKA may be a good dividend stock for its sector.

Based on targets from 4 analysts, the average taret price for ORKA is USD 42.50 over the next 12 months. The maximum analyst target price is USD 45 while the minimum anlayst target price is USD 40.

Unfortunately we do not have enough data on ORKA's stock to indicate if its overvalued.

The last closing price of ORKA's stock was USD 25.65.

The most recent market capitalization for ORKA is USD 0.89B.

Based on targets from 4 analysts, the average taret price for ORKA is projected at USD 42.50 over the next 12 months. This means that ORKA's stock price may go up by +65.69% over the next 12 months.

We can't find any ETFs which contains Oruka Therapeutics, Inc.'s stock.

Sorry, we do not have any data on the number of employees for Oruka Therapeutics, Inc..

Sorry we do not have any infomation available on Oruka Therapeutics, Inc.'s address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About Oruka Therapeutics, Inc. (ORKA) Stock

Based on ratings from 4 analysts Oruka Therapeutics, Inc.'s stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bullish. The stock has 4 buy, sell and hold ratings.

ORKA stock's dividend yield is 77.77%. Our analysis grades ORKA stock's dividend yield at A+. This means that ORKA stock's dividend yield is above 97% of the stocks in the Others sector in the NSD exchange. Based on this ORKA may be a good dividend stock for its sector.

Based on targets from 4 analysts, the average taret price for ORKA is USD 42.50 over the next 12 months. The maximum analyst target price is USD 45 while the minimum anlayst target price is USD 40.

Unfortunately we do not have enough data on ORKA's stock to indicate if its overvalued.

The last closing price of ORKA's stock was USD 25.65.

The most recent market capitalization for ORKA is USD 0.89B.

Based on targets from 4 analysts, the average taret price for ORKA is projected at USD 42.50 over the next 12 months. This means that ORKA's stock price may go up by +65.69% over the next 12 months.

We can't find any ETFs which contains Oruka Therapeutics, Inc.'s stock.

Sorry, we do not have any data on the number of employees for Oruka Therapeutics, Inc..

Sorry we do not have any infomation available on Oruka Therapeutics, Inc.'s address.
Loading...